Identifying drug-related problems in hospitalized patients
Incidence and Risk Factor of Drug Related Problem Detected in Inpatient
This study looks at how pharmacists can find and fix medication problems for patients who are admitted to the hospital to help keep them safe and improve their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03476733 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on identifying and addressing drug-related problems (DRPs) in inpatient settings. A team of pharmacists conducts a medication reconciliation process shortly after patient admission, which includes gathering a comprehensive medication history and comparing it with the physician's prescriptions. The pharmacists then classify and document any identified DRPs, assessing their potential clinical impact through expert consensus. This approach aims to enhance medication safety and improve patient outcomes by addressing issues related to medication errors.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged over 18 who are admitted to the hospital and expected to stay for at least 24 hours.
Not a fit: Patients who are not hospitalized or those who are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce medication errors and improve health outcomes for hospitalized patients.
How similar studies have performed: Other studies have shown success in reducing medication errors through similar pharmacist-led interventions, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: \- Patients aged above 18 years old, admitted to the department during the study period and hospitalized for at least 24 hours Exclusion criteria: \- NA
Where this trial is running
Montpellier
- Uhmontpellier — Montpellier, France (Recruiting)
Study contacts
- Principal investigator: Cyril BREUKER — University Hospital, Montpellier
- Study coordinator: Cyril BREUKER, PharmD,Phd
- Email: c-breuker@chu-montpellier.fr
- Phone: 467337121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.